The Insight Partners

Advanced Wound Care Market Is Growing at a Revenue of $11,564.6 Million by 2025

Increasing prevalence of diabetes & related chronic wounds is driving the market for advance wound care over the forecast period.

 

Pune, India -- (SBWIRE) -- 03/14/2019 -- Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. According to the International Diabetes Federation (IDF), in 2017, number of people with diabetes in North America was approximately 46 million which is expected to grow at 62 million in 2045. The increase in the disease prevalence is around 35% during the forecast period. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries up to 91% of adults with the disease have type 2 diabetes. As per the report of IDF, one in 11 adults have diabetes in 2015, and it will decrease to one in 10 adults till 2040.

Advanced Wound Care Market to 2025 - Global Analysis and Forecasts By Product (Dressings, Devices, and Bioactives), Wound Type (Surgical, Trauma, Burns, Ulcers, Diabetic Foot, Others), End User (Hospitals & Clinics, Ambulatory Care Centers, Wound Care Centers, and Others) and Geography

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100000825

The global advanced wound care market accounted to US$ 8,181.9 Mn in 2017 and is expected to grow at a CAGR of 4.5% during the forecast period 2018 – 2025, to account to US$ 11,564.6 Mn by 2025.

Strategic Insights

Approvals and agreements were observed as the most adopted strategy in global advanced wound care industry. Few of the recent product launch and collaboration and others are listed below:

2018: In April, 2018, Kerecis proposed the study results in Symposium on Advanced Wound Care (SAWC) Spring meeting to be held April 25 to 28. Kerecis is exhibiting at booth 230 at the Charlotte Convention Center.

2017: In October, 2017, Integra LifeSciences Launches Integra SurgiMend PRS Meshed Collagen Matrix For Breast Reconstruction In Europe.

2016: In April 2016, Integra LifeSciences Announces Agreement With Vomaris Wound Care, Inc. To Commercialize VolTAC Antimicrobial Wound Dressing.

Check the Discount on this Report at https://www.theinsightpartners.com/discount/TIPHE100000825

Table of Contents Overview:

Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Methodology
3.2.1 Data Collection
3.2.2 Data Analysis
3.2.3 Data Validation
3.3 Research Sources
3.3.1 Primary Sources
3.3.2 Secondary Sources
3.3.3 Assumptions

Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Advanced Wound Care Market Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Direct Purchase this Report at https://www.theinsightpartners.com/buy/TIPHE100000825